Immune responses to azacytidine in animal models of inflammatory disorders: a systematic review
Abstract Inflammatory disorders like diabetes, systemic lupus erythematodes, inflammatory lung diseases, rheumatoid arthritis and multiple sclerosis, but also rejection of transplanted organs and GvHD, form a major burden of disease. Current classes of immune suppressive drugs to treat these disorde...
Main Authors: | Sija Landman, Chiel van der Horst, Piet E. J. van Erp, Irma Joosten, Rob de Vries, Hans J. P. M. Koenen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-020-02615-2 |
Similar Items
-
5-Azacytidine in chronic myelomonocytic leukemia: case report and review of literature
by: Marianna Criscuolo, et al.
Published: (2011-01-01) -
5-Azacytidine in chronic myelomonocytic leukemia: case report and review of literature
by: Mariangela Greco, et al.
Published: (2011-03-01) -
5-Azacytidine restores interleukin 6-increased production in mesenchymal stromal cells from myelodysplastic patients
by: Matilde Boada, et al.
Published: (2021-01-01) -
The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry
by: Panagiotis Diamantopoulos, et al.
Published: (2019-05-01) -
A Comparative Analysis of 5-Azacytidine- and Zebularine-Induced DNA Demethylation
by: Patrick T. Griffin, et al.
Published: (2016-09-01)